786 related articles for article (PubMed ID: 17903340)
1. The -675 4G/5G polymorphism at the Plasminogen Activator Inhibitor 1 (PAI-1) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption.
Pérez-Martínez P; Adarraga-Cansino MD; Fernández de la Puebla RA; Blanco-Molina A; Delgado-Lista J; Marín C; Ordovás JM; López-Miranda J; Pérez-Jiménez F
Br J Nutr; 2008 Apr; 99(4):699-702. PubMed ID: 17903340
[TBL] [Abstract][Full Text] [Related]
2. The effect of apoE genotype and sex on ApoE plasma concentration is determined by dietary fat in healthy subjects.
Moreno JA; Pérez-Jiménez F; Moreno-Luna R; Pérez-Martínez P; Fuentes-Jiménez F; Marín C; Portugal H; Lairon D; López-Miranda J
Br J Nutr; 2009 Jun; 101(12):1745-52. PubMed ID: 19025720
[TBL] [Abstract][Full Text] [Related]
3. The APOB -516C/T polymorphism has no effect on lipid and apolipoprotein response following changes in dietary fat intake in a healthy population.
Perez-Martinez P; Perez-Jimenez F; Ordovas JM; Bellido C; Moreno JA; Gomez P; Marin C; Fernandez de la Puebla RA; Paniagua JA; Lopez-Miranda J
Nutr Metab Cardiovasc Dis; 2007 Mar; 17(3):224-9. PubMed ID: 17367707
[TBL] [Abstract][Full Text] [Related]
4. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
[TBL] [Abstract][Full Text] [Related]
5. The effect of plasminogen activator inhibitor-1 gene 4G/5G polymorphism on glucose and lipid metabolisms in Turkish obese children.
Kinik ST; Ataç FB; Verdi H; Cetintaş S; Sahin FI; Ozbek N
Clin Endocrinol (Oxf); 2005 May; 62(5):607-10. PubMed ID: 15853833
[TBL] [Abstract][Full Text] [Related]
6. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
[TBL] [Abstract][Full Text] [Related]
7. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.
Matsubara Y; Murata M; Isshiki I; Watanabe R; Zama T; Watanabe G; Watanabe K; Ikeda Y
Int J Hematol; 1999 Jan; 69(1):43-7. PubMed ID: 10641442
[TBL] [Abstract][Full Text] [Related]
8. PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample.
Meigs JB; Dupuis J; Liu C; O'Donnell CJ; Fox CS; Kathiresan S; Gabriel SB; Larson MG; Yang Q; Herbert AG; Wilson PW; Feng D; Tofler GH; Cupples LA
Obesity (Silver Spring); 2006 May; 14(5):753-8. PubMed ID: 16855181
[TBL] [Abstract][Full Text] [Related]
9. The APOB -516C/T polymorphism is associated with differences in insulin sensitivity in healthy males during the consumption of diets with different fat content.
Pérez-Martínez P; Pérez-Jiménez F; Ordovás JM; Moreno JA; Moreno R; Fuentes F; Ruano J; Gómez P; Marín C; López-Miranda J
Br J Nutr; 2007 Apr; 97(4):622-7. PubMed ID: 17349073
[TBL] [Abstract][Full Text] [Related]
10. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctus du Mycocarde.
Ye S; Green FR; Scarabin PY; Nicaud V; Bara L; Dawson SJ; Humphries SE; Evans A; Luc G; Cambou JP
Thromb Haemost; 1995 Sep; 74(3):837-41. PubMed ID: 8571307
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
Jorgenson E; Deitcher SR; Cicek M; Liu X; Plummer S; Casey G; Witte JS
Prostate; 2007 Feb; 67(2):172-7. PubMed ID: 17044080
[TBL] [Abstract][Full Text] [Related]
12. Postoperative bleeding in cardiac surgery: the role of tranexamic acid in patients homozygous for the 5G polymorphism of the plasminogen activator inhibitor-1 gene.
Iribarren JL; Jimenez JJ; Hernández D; Brouard M; Riverol D; Lorente L; de La Llana R; Nassar I; Perez R; Martinez R; Mora ML
Anesthesiology; 2008 Apr; 108(4):596-602. PubMed ID: 18362590
[TBL] [Abstract][Full Text] [Related]
13. Association of plasminogen activator inhibitor-1 4G/5G gene polymorphism with variations in the LDL particle size in healthy Japanese men.
Kitamura Y; Okumura K; Imamura A; Mizuno T; Tsuzuki M; Numaguchi Y; Matsui H; Murohara T
Clin Chim Acta; 2004 Sep; 347(1-2):209-16. PubMed ID: 15313160
[TBL] [Abstract][Full Text] [Related]
14. Interaction between smoking and the Sstl polymorphism of the apo C-III gene determines plasma lipid response to diet.
Pérez-Martínez P; Gómez P; Paz E; Marín C; Gavilán Moral E; López-Miranda J; Ordovas JM; Fernandez de la Puebla RA; Pérez-Jiménez F
Nutr Metab Cardiovasc Dis; 2001 Aug; 11(4):237-43. PubMed ID: 11837227
[TBL] [Abstract][Full Text] [Related]
15. Influence of the 4G/5G PAI-1 genotype on angiotensin II-stimulated human endothelial cells and in patients with hypertension.
Roncal C; Orbe J; Rodriguez JA; Belzunce M; Beloqui O; Diez J; Páramo JA
Cardiovasc Res; 2004 Jul; 63(1):176-85. PubMed ID: 15194475
[TBL] [Abstract][Full Text] [Related]
16. Role of the 4G/5G polymorphism of PaI-1 gene promoter on PaI-1 levels in obese patients: influence of fat distribution and insulin-resistance.
Sartori MT; Vettor R; De Pergola G; De Mitrio V; Saggiorato G; Della Mea P; Patrassi GM; Lombardi AM; Fabris R; Girolami A
Thromb Haemost; 2001 Nov; 86(5):1161-9. PubMed ID: 11816701
[TBL] [Abstract][Full Text] [Related]
17. Effect of 4G/5G PAI-1 polymorphism on the response of PAI-1 activity to vitamin E supplementation in Type 2 diabetic patients.
Testa R; Bonfigli AR; Sirolla C; Boemi M; Manfrini S; Mari D; Testa I; Sacchi E; Franceschi C
Diabetes Nutr Metab; 2004 Aug; 17(4):217-21. PubMed ID: 15575342
[TBL] [Abstract][Full Text] [Related]
18. [The influences of genetic and environmental factors on plasma plasminogen activator inhibitor-1 levels in patients with essential hypertension].
Song Y; Xu W; Chen Y; Che L; Wang Q; Zhou X; Wu J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Dec; 16(6):374-6. PubMed ID: 10581347
[TBL] [Abstract][Full Text] [Related]
19. Plasma PAI-1 levels in obese children--effect of weight loss and influence of PAI-1 promoter 4G/5G genotype.
Estellés A; Dalmau J; Falcó C; Berbel O; Castelló R; España F; Aznar J
Thromb Haemost; 2001 Aug; 86(2):647-52. PubMed ID: 11522017
[TBL] [Abstract][Full Text] [Related]
20. A monounsaturated fatty acid-rich diet reduces macrophage uptake of plasma oxidised low-density lipoprotein in healthy young men.
Moreno JA; López-Miranda J; Pérez-Martínez P; Marín C; Moreno R; Gómez P; Paniagua JA; Pérez-Jiménez F
Br J Nutr; 2008 Sep; 100(3):569-75. PubMed ID: 18226292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
